FDA Finalizes Guidance on Transfer of 510(k) Clearances
FDA has issued final guidance clarifying when a transferred 510(k) clearance requires a new submission, as well as registration, listing, UDI and GUDID obligations for the new holder.
NIST Publishes New Cybersecurity Guide for Small Businesses and Solopreneurs
NIST has published CSWP 50, a practical cybersecurity guide helping non-employer firms and very small businesses apply the NIST Cybersecurity Framework 2.0.
WHO Publishes Toolkit of SOPs for Bacteriology, Mycology and Antimicrobial Susceptibility Testing
WHO has published a 2026 toolkit with more than 70 SOPs for bacteriology, mycology and antimicrobial susceptibility testing, covering specimen management, culture, identification, resistance testing, biosafety, quality control and reporting.
WHO Publishes Essential Diagnostic Test Package for Bacterial and Fungal Infections and Antimicrobial Resistance
WHO has published a new essential package of diagnostic tests for bacterial and fungal infections and antimicrobial resistance, defining priority testing across primary care and hospital levels.
IMDRF Opens Call for Training Providers for New Endorsement Model Pilot
IMDRF has opened a call for external organisations to participate as training providers in its Training Endorsement Model Pilot, with applications due by 15 December 2026.
EU Expert Panel Warns of Clinical Impact from Shortage of Critical Cardiac Cannulae and Catheters
An EU expert panel has assessed a possible Union-wide MDR derogation for Andocor cardiac cannulae and catheters, warning that supply shortages could significantly affect cardiac surgery and patient care.
MDSAP Updates Audit Time Determination Procedure for Medical Device Manufacturers
MDSAP has issued Version 009 of its Audit Time Determination Procedure, updating references and criteria used by recognised Auditing Organizations to calculate audit duration for medical device manufacturers.
TGA Updates UDI Compliance Timeframes for Medical Devices in Australia
Australia’s TGA has updated its guidance on UDI compliance timeframes for medical devices, correcting EU IVDD to IVDR transitional arrangement dates and clarifying phased implementation requirements.
ENISA and CERT-EU Find Frontier AI Can Accelerate Security Code Review — but Human Validation Remains Essential
ENISA and CERT-EU tested frontier AI models on 27 open-source codebases, identifying 220 potential issues. Of 88 findings reviewed by code owners, 95% were confirmed as true positives, while human validation remained essential.
Swissmedic Extends Deadline for Publishing Officially Mandated Safety Information Materials
Swissmedic has extended the deadline to 31 December 2026 for publishing outstanding officially mandated safety information materials on its electronic publication platforms.
FDA Seeks Feedback on Benefit-Risk Evaluation for Autonomous and Remote Robotic Medical Devices
FDA has published a discussion paper on benefit-risk evaluation for robotic medical devices with autonomous or remote teleoperation capabilities, highlighting autonomy, connectivity, cybersecurity, human factors and postmarket oversight.
MHRA Updates Medical Device Registration Guidance for Great Britain and Northern Ireland
The MHRA has updated its medical device registration guidance, covering DORS, annual fees, EUDAMED requirements for Northern Ireland, UK Responsible Persons, importers and device registration changes.
European Commission M/575 Standardisation Request Remains Under Execution Through 2028
The European Commission’s M/575 standardisation request for MDR and IVDR remains under execution until 31 December 2028, with CEN and CENELEC supporting the development of harmonised standards for medical devices and IVDs.
European Commission Publishes New Harmonised Standards Decisions for MDR and IVDR
The European Commission has updated the harmonised standards framework for medical devices and IVDs with new implementing decisions under the MDR and IVDR published in November 2026.
FDA Finalizes Guidance on Validation of IVDs for Emerging Pathogens During Declared Emergencies
FDA has finalized guidance on validation of certain IVDs for emerging pathogens during Section 564 declared emergencies, covering clinical performance, LoD, inclusivity, usability, cybersecurity, change protocols and home and POC testing.
Swissmedic Launches 2027 Pilot for eCTD v4.0 Submissions
Swissmedic will introduce eCTD v4.0 through a pilot between January and April 2027, covering initial and follow-up submissions and based on the Swiss Implementation Guide v2.0.
Team-NB Calls for Targeted Reform of the MDR Clinical Evaluation Consultation Procedure
Team-NB has published a position paper on the MDR Clinical Evaluation Consultation Procedure, calling for greater predictability, transparency, proportionality and clearer clinical evidence expectations.
FDA Highlights 10 Years of Medical Device Cybersecurity Work
The FDA marks 10 years of its medical device cybersecurity team, highlighting its role in patient safety, vulnerability response and cybersecurity across the Total Product Life Cycle.
MHRA Updates Guidance on Clinical Investigations for Medical Devices
The MHRA has updated its guidance on medical device clinical investigations, including fee waivers for SMEs, application procedures, assessment timelines, SAE reporting, PMCF-related requirements and Northern Ireland rules.
EU Expert Panel Challenges Clinical Benefit Claims for Novel Class III Knee Osteoarthritis Device
A CECP expert panel has questioned the clinical benefit and promotional claims of a novel Class III intra-articular device for knee osteoarthritis, recommending stronger post-market evidence and revised PMCF activities.